Antimicrobial activity of a novel liposomal azithromycin formulation against clinical CF respiratory isolates

Autoria(s): Bashi, Y. D.; Payne, J.; McGrath, S. J.; Elborn, J. S.; Tunney, M. M.; Kett, V. L.
Data(s)

01/06/2016

31/12/1969
Identificador

http://pure.qub.ac.uk/portal/en/publications/antimicrobial-activity-of-a-novel-liposomal-azithromycin-formulation-against-clinical-cf-respiratory-isolates(85c7a565-8668-484d-b9af-2ec382edd15a).html

http://dx.doi.org/ 10.1016/S1569-1993(16)30236-3
Idioma(s)

eng
Direitos

info:eu-repo/semantics/embargoedAccess
Fonte

Bashi , Y D , Payne , J , McGrath , S J , Elborn , J S , Tunney , M M & Kett , V L 2016 , ' Antimicrobial activity of a novel liposomal azithromycin formulation against clinical CF respiratory isolates ' Journal of Cystic Fibrosis , vol 15 , no. S1 , ePs06.6 , pp. S49 . DOI: 10.1016/S1569-1993(16)30236-3
Tipo

article
Acesso ao item digital